Depression symptoms increase the risk for initiation or switching to biologic therapy in pediatric inflammatory bowel disease patients in remission

被引：0
|
作者：
F. Milo
G. Angelino
E.F. Romeo
P. De Angelis
P. Tabarini
机构：
[1] Bambino Gesù Children’s Hospital,Psychology Unit
[2] IRCCS,Gastroenterology and Nutrition Unit
[3] Bambino Gesù Children’s Hospital,undefined
[4] IRCCS,undefined
来源：
BMC Gastroenterology | / 23卷
关键词：
Pediatric; Inflammatory bowel disease; Depression; Anxiety; Biologic therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Depression symptoms increase the risk for initiation or switching to biologic therapy in pediatric inflammatory bowel disease patients in remission
    Milo, F.
    Angelino, G.
    Romeo, E. F.
    De Angelis, P.
    Tabarini, P.
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [2] Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease
    Hindryckx, Pieter
    Novak, Gregor
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (04) : 633 - 641
  • [3] Dual biologic therapy in pediatric Inflammatory Bowel Disease
    Abbas, R.
    Ibrahim, N.
    Elawad, M.
    Al-Mudahka, F.
    Abdelrhman, H.
    Akobeng, A. K.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 747 - 747
  • [4] Biologic therapy and the risk of herpes zoster among patients with inflammatory bowel disease
    Santella, Christina
    Bitton, Alain
    Filliter, Christopher
    Vutcovici, Maria
    Bessissow, Talat
    Lakatos, Peter
    Brassard, Paul
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 607 - 607
  • [5] Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease
    Roig, Clara Amiama
    Ferrer, Cristina Suarez
    Garcia, Jose Luis Rueda
    Cordon, Joaquin Poza
    Sanchez-Azofra, Maria
    Arranz, Eduardo Martin
    Diaz, Irene Gonzalez
    Costa, Carmen Amor
    Martin-Arranz, Maria Dolores
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (02): : 109 - 115
  • [6] ASSOCIATION OF BIOLOGIC THERAPY OVERLAP WITH THE RISK OF INFECTIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Kruger, Annie J.
    Dormont, Flavio
    Capit, Nicolas
    Schilsky, Samantha
    Roberts, Andrew
    Lin, Yong
    Badalamenti, Salvatore
    Wiekowski, Maria
    Bewtra, Meenakshi
    Colombel, Jean Frederic
    GASTROENTEROLOGY, 2024, 166 (05) : S1132 - S1133
  • [7] ANXIETY AND DEPRESSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS IN CLINICAL REMISSION: AN ASSESSMENT OF SELF-AND PARENT-REPORTED SYMPTOMS
    Musburger, Brooke
    Schwartz, Naomi R.
    Kawamura, Joy
    Lee, Dale
    Nuding, Mason E.
    Ford, Madeline
    Wahbeh, Ghassan
    Suskind, David
    GASTROENTEROLOGY, 2022, 162 (07) : S646 - S646
  • [8] Biologic Therapy in Inflammatory Bowel Disease
    Theede, Klaus
    Dahlerup, Jens Frederik
    Fallingborg, Jan
    Hvas, Christian Lodberg
    Kjeldsen, Jens
    Munck, Lars Kristian
    Nordgaard-Lassen, Inge
    DANISH MEDICAL JOURNAL, 2013, 60 (06):
  • [9] Biologic therapy of inflammatory bowel disease
    Sandborn, WJ
    Targan, SR
    GASTROENTEROLOGY, 2002, 122 (06) : 1592 - 1608
  • [10] Biologic therapy for inflammatory bowel disease
    Ardizzone, S
    Porro, GB
    DRUGS, 2005, 65 (16) : 2253 - 2286
12345